人工耳蜗植入对单侧聋患者的获益:House Clinic-南加州大学-加州大学洛杉矶分校临床试验数据
该前瞻性纵向研究纳入10例单侧聋患者,植入MED-EL CONCERTO Flex 28装置,在术前及开机后1、3、6个月评估言语识别、声源定位、耳鸣严重度和生活质量。结果显示人工耳蜗对耳鸣、定位、噪声下言语及生活质量均有显著获益,但获益程度和时程取决于结局指标与比较基准。
要点
- 单侧聋患者可从人工耳蜗植入中获得耳鸣、定位、噪声下言语及生活质量的显著获益。
- 人工耳蜗获益的程度和时程因结局指标和比较基准(术前双耳基线 vs 术后正常耳单独表现)而异。
- 行为学数据与问卷数据之间缺乏相关性,提示二者为独立的获益评价指标。
核心结论
- 行为学与主观数据表明单侧聋患者从人工耳蜗植入中显著获益。
- 评估人工耳蜗获益需考虑结局指标和比较基准,术前双耳基线表现是临床相关的比较点。
- 行为学数据与问卷数据缺乏相关性,提示二者为独立的人工耳蜗获益评价指标。
研究设计与样本
- 纵向、前瞻性、美国食品药品监督管理局批准的临床试验,共10例单侧聋患者完成研究。
- 所有患者一耳为重至极重度听力损失,另一耳听力正常,均植入MED-EL CONCERTO Flex 28装置。
- 在术前基线及开机后1、3、6个月测量安静与噪声下言语识别、声源定位及耳鸣严重度(人工耳蜗开或关)。
- 性能测量包括双耳、仅人工耳蜗耳、仅正常耳(人工耳蜗耳堵塞并加罩)。
- 术前及开机后6个月通过问卷评估耳鸣严重度、头晕严重度和生活质量。
主要发现
- 人工耳蜗在耳鸣严重度、声源定位、言语识别和生活质量方面均观察到显著获益。
- 相对于术前双耳基线,耳鸣严重度和噪声下言语表现在开机后1个月即出现显著获益,声源定位至开机后6个月才显著改善,生活质量问卷在开机后6个月显著改善。
- 相对于术后仅正常耳表现,耳鸣严重度和声源定位在开机后即出现显著获益;双耳噪声下言语理解在6个月研究期内未显著改善,归因于仅正常耳表现的变异性。
- 除开机后6个月耳鸣视觉模拟量表评分与耳鸣功能指数评分相关外,行为学数据与问卷数据之间无相关性。
临床怎么用
- 临床评估单侧聋患者人工耳蜗获益时,应采用术前双耳基线表现作为相关比较点。
- 应向患者说明不同结局指标(耳鸣、定位、噪声下言语、生活质量)的获益时程可能不同。
- 行为学测试与问卷评估应结合使用,因二者反映独立的人工耳蜗获益维度。
局限性
- 样本量较小,共10例患者完成研究。
- 随访时间至开机后6个月,为短期结果。
- 仅使用MED-EL CONCERTO Flex 28装置,结论外推需谨慎。
- 双耳噪声下言语未显著改善与仅正常耳表现的变异性有关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Cochlear implants (CIs) have been shown to benefit patients with single-sided deafness (SSD) in terms of tinnitus reduction, localization, speech understanding, and quality of life (QoL). While previous studies have shown cochlear implantation may benefit SSD patients, it is unclear which point of comparison is most relevant: baseline performance before implantation versus performance with normal-hearing (NH) ear after implantation. In this study, CI outcomes were assessed in SSD patients before and up to 6 mo postactivation. Benefits of cochlear implantation were assessed relative to binaural performance before implantation or relative to performance with the NH ear alone after implantation. DESIGN: Here, we report data for 10 patients who completed a longitudinal, prospective, Food and Drug Administration-approved study of cochlear implantation for SSD patients. All subjects had severe to profound unilateral hearing loss in one ear and normal hearing in the other ear. All patients were implanted with the MED-EL CONCERTO Flex 28 device. Speech understanding in quiet and in noise, localization, and tinnitus severity (with the CI on or off) were measured before implantation (baseline) and at 1, 3, 6 mo postactivation of the CI processor. Performance was measured with both ears (binaural), the CI ear alone, and the NH ear alone (the CI ear was plugged and muffed). Tinnitus severity, dizziness severity, and QoL were measured using questionnaires administered before implantation and 6 mo postactivation. RESULTS: Significant CI benefits were observed for tinnitus severity, localization, speech understanding, and QoL. The degree and time course of CI benefit depended on the outcome measure and the reference point. Relative to binaural baseline performance, significant and immediate (1 mo postactivation) CI benefits were observed for tinnitus severity and speech performance in noise, but localization did not significantly improve until 6 mo postactivation; questionnaire data showed significant improvement in QoL 6 mo postactivation. Relative to NH-only performance after implantation, significant and immediate benefits were observed for tinnitus severity and localization; binaural speech understanding in noise did not significantly improve during the 6-mo study period, due to variability in NH-only performance. There were no correlations between behavioral and questionnaire data, except between tinnitus visual analog scale scores at 6 mo postactivation and Tinnitus Functional Index scores at 6 mo postactivation. CONCLUSIONS: The present behavioral and subjective data suggest that SSD patients greatly benefit from cochlear implantation. However, to fully understand the degree and time course of CI benefit, the outcome measure and point of comparison should be considered. From a clinical perspective, binaural baseline performance is a relevant point of comparison. The lack of correlation between behavioral and questionnaire data suggest that represent independent measures of CI benefit for SSD patients.
引用
- Galvin JJ, Fu QJ, Wilkinson EP, et al. Benefits of Cochlear Implantation for Single-Sided Deafness: Data From the House Clinic-University of Southern California-University of California, Los Angeles Clinical Trial. Ear Hear. 2019. PMID: 30358655. doi:10.1097/AUD.0000000000000671
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。